MARKET

IQV

IQV

IQVIA Holdings
NYSE

Real-time Quotes | Nasdaq Last Sale

187.80
-0.98
-0.52%
After Hours: 187.80 0 0.00% 16:42 03/08 EST
OPEN
191.47
PREV CLOSE
188.78
HIGH
194.95
LOW
187.62
VOLUME
917.47K
TURNOVER
--
52 WEEK HIGH
199.99
52 WEEK LOW
81.79
MARKET CAP
36.01B
P/E (TTM)
131.69
1D
5D
1M
3M
1Y
5Y
IQVIA Holdings Inc. stock outperforms market despite losses on the day
Shares of IQVIA Holdings Inc. slid 0.52% to $187.80 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...
marketwatch.com · 9h ago
BRIEF-Iqvia Collaborating With Janssen Research & Development On Their Investigational Covid-19 Vaccine Trials
reuters.com · 18h ago
IQVIA Says Since Sept. Has Been Collaborating With Janssen On Phase 3 COVID-19 Vaccine Trial, Says 'The studies leverage IQVIA's suite of decentralized trial solutions'; Financial Details Not Disclosed
QVIA™ (NYSE:IQV) announces that since September 2020 it has been collaborating with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, on the Phase 3
Benzinga · 18h ago
IQVIA Collaborating with Janssen Research & Development on Their Investigational COVID-19 Vaccine Trials
IQVIA™ (NYSE: IQV) announces that since September 2020 it has been collaborating with Janssen Research & Development, LLC, one of the Janssen...
BusinessWire - BZX · 18h ago
DJ IQVIA Holdings Price Target Announced at $218.00/Share by KeyBanc
Dow Jones · 21h ago
DJ IQVIA Holdings Raised to Overweight From Sector Weight by KeyBanc
Dow Jones · 21h ago
Analyst Actions: KeyBanc Upgrades IQVIA Holdings to Overweight From Sector Weight, Sets $218 Price Target
MT Newswires · 1d ago
IQVIA Holdings Inc. stock rises Friday, still underperforms market
Shares of IQVIA Holdings Inc. rose 1.18% to $188.78 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...
marketwatch.com · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IQV. Analyze the recent business situations of IQVIA Holdings through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 22 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IQV stock price target is 219.32 with a high estimate of 238.00 and a low estimate of 180.00.
EPS
Institutional Holdings
Institutions: 895
Institutional Holdings: 168.40M
% Owned: 87.81%
Shares Outstanding: 191.77M
TypeInstitutionsShares
Increased
306
10.08M
New
153
-699.89K
Decreased
226
10.13M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.02%
Pharmaceuticals & Medical Research
-0.50%
Key Executives
Chairman/President/Chief Executive Officer/Director
Ari Bousbib
Chief Financial Officer/Executive Vice President
Ronald Bruehlman
Corporate Executive
Kevin Knightly
Corporate Executive
W. Richard Staub
Corporate Executive
Walter Staub
Executive Vice President/General Counsel/Secretary
Erlinger Sherbet
Executive Vice President/General Counsel/Secretary
Eric Sherbet
Lead Director/Independent Director
John Leonard
Independent Director
Carol Burt
Independent Director
John Connaughton
Independent Director
John Danhakl
Independent Director
James Fasano
Independent Director
Colleen Goggins
Independent Director
Ronald Rittenmeyer
Independent Director
Todd Sisitsky
No Data
  • All
  • Financials
  • Insiders
More
About IQV
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.

Webull offers kinds of Iqvia Holdings Inc stock information, including NYSE:IQV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IQV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IQV stock methods without spending real money on the virtual paper trading platform.